Now, it’s worth noting Stock Advisor's total average return is 991% — a market-crushing outperformance compared to 195% for ...
Discover why Crispr Therapeutics AG is a strong buy with FDA-approved Casgevy, a promising pipeline, and major growth ...
Goldenberries taste like a cross between pineapple and mango, pack the nutritional punch of a superfood, and are increasingly ...
Despite a challenging CASGEVY launch, high cash burn, and an almost 10% YTD share count growth, CRISPR’s pipeline breadth and ...
Casgevy, now a "national priority" drug, helped kids with sickle cell and thalassemia, results which may help toward a label ...
JUPITER, Fla. and DUBLIN, Nov. 10, 2025 (GLOBE NEWSWIRE) -- ERS Genomics Limited (‘ERS’), the CRISPR licensing company, and Dyadic Applied BioSolutions, a global biotechnology company producing ...
Dyadic International Inc (NASDAQ:DYAI) has successfully transitioned from a platform-centric R&D organization to a commercially focused biotechnology company. The company achieved its first commercial ...
Bengaluru-based biotechnology startup CrisprBits Private Limited has raised USD 3 Million through founders, angels & family ...
ZME Science on MSN
Scientists Engineered a Supercharged Quorn Fungus That Makes Nearly Double the Protein
Scientists grew a microscopic fungus into a more efficient — and meat-like — edible protein by tweaking just two genes with ...
(MENAFN- GlobeNewsWire - Nasdaq) JUPITER, Fla. and DUBLIN, Nov. 10, 2025 (GLOBE NEWSWIRE) -- ERS Genomics Limited ('ERS'), the CRISPR licensing company, and Dyadic Applied BioSolutions, a global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback